SCHEMBL14877486

SCHEMBL14877486

CC(=O)C(=O)Nc1cc(C)on1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 11/20 0.63
NPC1 O15118 8/20 0.63
MAPT P10636 2/20 0.62
SMN1; SMN2 Q16637 4/20 0.59
HPGD P15428 1/20 0.59
ALDH1A1 P00352 4/20 0.59
EGFR P00533 1/20 0.59
GAA P10253 1/20 0.59
TSHR P16473 2/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
KDM4E B2RXH2 1/20 0.54
TP53 P04637 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
CYP1A2 P05177 1/20 0.53
CYP2C19 P33261 1/20 0.53
GAPDH P04406 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15255707 0.85 RAB9A (0.63) RAB9ANPC1MAPTSMN1; SMN2HPGD
SCHEMBL1430419 0.84 MAPT (0.67) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL1888991 0.82 MAPT (0.69) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL13613088 0.80 RAB9A (0.58) RAB9ANPC1MAPTSMN1; SMN2HPGD
SCHEMBL12236808 0.79 RAB9A (0.65) RAB9ANPC1MAPTSMN1; SMN2HPGD
SCHEMBL12213910 0.79 RAB9A (0.56) RAB9ANPC1MAPTSMN1; SMN2HPGD
SCHEMBL5803752 0.78 MAPT (0.65) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL172042 0.78 MAPT (0.65) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL171882 0.78 MAPT (0.70) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL15427115 0.77 MAPT (1.00) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426359-B2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-04-23 US disclosed